Extracellular-regulated kinase - Mitogen-activated protein kinase cascade: Unsolved issues

Journal of Cellular Biochemistry

Volumn 109, Issue 5, 2010, Pages 850-857

  Bodart, Jean François L ^a  

^a UNIV LILLE   (France)

Author keywords

G2 M transition; MAPK; Post translational modifications; Regulation motif; Spatiotemporal dynamics

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; ONCOPROTEIN; RAF PROTEIN; RAS PROTEIN;

ANEUPLOIDY; BIOCHEMISTRY; BREAST CARCINOGENESIS; CARCINOGENESIS; CELL CYCLE; CELL CYCLE G2 PHASE; CELL CYCLE PROGRESSION; CELL FATE; CELL STRAIN; CELL TRANSFORMATION; CENTROSOME; COLON; FLUORESCENCE RESONANCE ENERGY TRANSFER; GAMETE; GLIOBLASTOMA; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; KIDNEY; LUNG PARENCHYMA; MITOSIS; MOLECULAR BIOLOGY; NONHUMAN; OOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SOMATIC CELL; TUMOR CELL; UPREGULATION; WESTERN BLOTTING;

ANIMALS; CELL CYCLE; CELL TRANSFORMATION, NEOPLASTIC; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENOMIC INSTABILITY; GLYCOSYLATION; HUMANS; MAP KINASE SIGNALING SYSTEM;

EID: 77950413847     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22477     Document Type: Review

References (49)

1. Ai HW, Hazelwood KL, Davidson MW, Campbell RE. 2008. Fluorescent protein FRET pairs for ratiometric imaging of dual biosensors. Nat Methods 5:401-403.
2. Amiel A, Leclere L, Robert L, Chevalier S, Houliston E. 2009. Conserved functions for Mos in eumetazoan oocyte maturation revealed by studies in a cnidarian. Curr Biol 19:305-311.
3. Arbuthnot P, Capovilla A, Kew M. 2000. Putative role of hepatitis B virus X protein in hepatocarcinogenesis: Effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathways. J Gastroenterol Hepatol 15:357-368.
4. Baert F, Bodart JF, Bocquet-Muchembled B, Lescuyer-Rousseau A, Vilain JP. 2003. Xp42(Mpk1) activation is not required for germinal vesicle breakdown but for Raf complete phosphorylation in insulin-stimulated Xenopus oocytes. J Biol Chem 278:49714-49720.
5. Bhalla US, Ram PT, Iyengar R. 2002. MAP kinase phosphatase as a locus of flexibility in a mitogen-activated protein kinase signaling network. Science 297:1018-1023.
6. Bodart JF, Baert FY, Sellier C, Duesbery NS, Flament S, Vilain JP. 2005. Differential roles of p39Mos-Xp42Mpk1 cascade proteins on Raf1 phosphorylation and spindle morphogenesis in Xenopus oocytes. Dev Biol 283:373-383.
7. Bodart JF, Chopra A, Liang X, Duesbery N. 2002. Anthrax, MEK and cancer. Cell Cycle 1:10-15.
8. Brightman FA, Fell DA. 2000. Differential feedback regulation of the MAPK cascade underlies the quantitative differences in EGF and NGF signalling in PC12 cells. FEBS Lett 482:169-174.
9. Campagna M, Beffy P, Del Carratore R, Hauri L, Simi S, Bonatti S, Simili M. 2003. Diethylsulphate and methylnitrosourea affect different targets in Chinese hamster fibroblasts: Possible mechanisms of aneuploidy induction by these agents. Mutagenesis 18:405-410.
10. Dehennaut V, Hanoulle X, Bodart JF, Vilain JP, Michalski JC, Landrieu I, Lippens G, Lefebvre T. 2008a. Microinjection of recombinant O-GlcNAc transferase potentiates Xenopus oocytes M-phase entry. Biochem Biophys Res Commun 369:539-546.
11. Dehennaut V, Lefebvre T, Sellier C, Leroy Y, Gross B, Walker S, Cacan R, Michalski JC, Vilain JP, Bodart JF. 2007. O-linked N-acetylglucosaminyl- transferase inhibition prevents G2/M transition in Xenopus laevis oocytes. J Biol Chem 282:12527-12536.
12. Dehennaut V, Slomianny MC, Page A, Vercoutter-Edouart AS, Jessus C, Michalski JC, Vilain JP, Bodart JF, Lefebvre T. 2008b. Identification of structural and functional O-linked N-acetylglucosamine-bearing proteins in Xenopus laevis oocyte. Mol Cell Proteomics 7:2229-2245.
13. Dupre A, Suziedelis K, Valuckaite R, de Gunzburg J, Ozon R, Jessus C, Haccard O. 2002. Xenopus H-RasV12 promotes entry into meiotic M phase and cdc2 activation independently of Mos and p42(MAPK). Oncogene 21:6425-6433.
14. Ferrell JE, Jr., Machleder EM. 1998. The biochemical basis of an all-or-none cell fate switch in Xenopus oocytes. Science 280:895-898.
15. Fukasawa K, Vande Woude GF. 1997. Synergy between the Mos/ mitogen-activated protein kinase pathway and loss of p53 function in transformation and chromosome instability. Mol Cell Biol 17:506-518.
16. Goldbeter A, Koshland DE, Jr. 1981. An amplified sensitivity arising from covalent modification in biological systems. Proc Natl Acad Sci USA 78:6840-6844.
17. Haccard O, Jessus C. 2006. Oocyte maturation, Mos and cyclins-A matter of synthesis: Two functionally redundant ways to induce meiotic maturation. Cell Cycle 5:1152-1159.
18. Harvey CD, Ehrhardt AG, Cellurale C, Zhong H, Yasuda R, Davis RJ, Svoboda K. 2008. A genetically encoded fluorescent sensor of ERK activity. Proc Natl Acad Sci USA 105:19264-19269.
19. Horne MM, Guadagno TM. 2003. A requirement for MAP kinase in the assembly and maintenance of the mitotic spindle. J Cell Biol 161:1021-1028.
20. Justman QA, Serber Z, Ferrell JE, Jr., El-Samad H, Shokat KM. 2009. Tuning the activation threshold of a kinase network by nested feedback loops. Science 324:509-512.
21. Kholodenko BN. 2007. Untangling the signalling wires. Nat Cell Biol 9:247-249.
22. Kotani T, Yamashita M. 2002. Discrimination of the roles of MPF and MAP kinase in morphological changes that occur during oocyte maturation. Dev Biol 252:271-286.
23. Mansour SJ, Matten WT, Hermann AS, Candia JM, Rong S, Fukasawa K, Vande Woude GF, Ahn NG. 1994. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265:966-970.
24. Markevich NI, Tsyganov MA, Hoek JB, Kholodenko BN. 2006. Long-range signaling by phosphoprotein waves arising from bistability in protein kinase cascades. Mol Syst Biol 2:61.
25. Marshall CJ. 1995. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179-185.
26. Murphy LO, Blenis J. 2006. MAPK signal specificity: The right place at the right time. Trends Biochem Sci 31:268-275.
27. Murphy LO, Smith S, Chen RH, Fingar DC, Blenis J. 2002. Molecular interpretation of ERK signal duration by immediate early gene products. Nat Cell Biol 4:556-564.
28. Neves SR, Tsokas P, Sarkar A, Grace EA, Rangamani P, Taubenfeld SM, Alberini CM, Schaff JC, Blitzer RD, Moraru II, Iyengar R. 2008. Cell shape and negative links in regulatory motifs together control spatial information flow in signaling networks. Cell 133:666-680.
29. Okazaki K, Sagata N. 1995. MAP kinase activation is essential for oncogenic transformation of NIH3T3 cells by Mos. Oncogene 10:1149-1157.
30. Roberts EC, Hammond K, Traish AM, Resing KA, Ahn NG. 2006. Identification of G2/M targets for the MAP kinase pathway by functional proteomics. Proteomics 6:4541-4553.
31. Roberts EC, Shapiro PS, Nahreini TS, Pages G, Pouyssegur J, Ahn NG. 2002. Distinct cell cycle timing requirements for extracellular signal-regulated kinase and phosphoinositide 3-kinase signaling pathways in somatic cell mitosis. Mol Cell Biol 22:7226-7241.
32. Rubinfeld H. Seger R. The ERK cascade: A prototype of MAPK signaling Molecular Biotechnology 2005 31 2 151-174 DOI 10.1385/MB:31:2:151
33. Rubinfeld H, Seger R. 2005. The ERK cascade: A prototype of MAPK signaling. Mol Biotechnol 31:151-174. (Pubitemid 41306584)
34. Russo C, Beaujois R, Bodart JF, Blossey R. (2009a). Kicked by Mos and tuned by MPF-The initiation of the MAPK cascade in Xenopus oocytes. HFSP J. DOI: 10.2976/1.3265771.
35. Russo C, Giuraniuc C, Blossey R, Bodart JF. 2009b. On the equilibria of the MAPK cascade: Cooperativity, modularity and bistability. Phys A 388:5070-5080.
36. Saavedra HI, Fukasawa K, Conn CW, Stambrook PJ. 1999. MAPK mediates RAS-induced chromosome instability. J Biol Chem 274:38083-38090.
37. Santos SD, Verveer PJ, Bastiaens PI. 2007. Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate. Nat Cell Biol 9:324-330.
38. Sasagawa S, Ozaki Y, Fujita K, Kuroda S. 2005. Prediction and validation of the distinct dynamics of transient and sustained ERK activation. Nat Cell Biol 7:365-373.
39. Shinohara M, Mikhailov AV, Aguirre-Ghiso JA, Rieder CL. 2006. Extracellular signal-regulated kinase 1/2 activity is not required in mammalian cells during late G2 for timely entry into or exit from mitosis. Mol Biol Cell 17:5227-5240.
40. Steffen M, Scherdin U, Vertes I, Boecker W, Dietel M, Holzel F. 1992. Karyotype instability and altered differentiation of rat sarcoma cells after retroviral infection. Genes Chromosomes Cancer 4:46-57.
41. Tomosugi W, Matsuda T, Tani T, Nemoto T, Kotera I, Saito K, Horikawa K, Nagai T. 2009. An ultramarine fluorescent protein with increased photostability and pH insensitivity. Nat Methods 6:351-353.
42. Ventura AC, Sepulchre JA, Merajver SD. 2008. A hidden feedback in signaling cascades is revealed. PLoS Comput Biol 4:e1000041.
43. Verlhac MH, Lefebvre C, Kubiak JZ, Umbhauer M, Rassinier P, Colledge W, Maro B. 2000. Mos activates MAP kinase in mouse oocytes through two opposite pathways. EMBO J 19:6065-6074.
44. Verveer PJ, Bastiaens PI. 2008. Quantitative microscopy and systems biology: Seeing the whole picture. Histochem Cell Biol 130:833-843.
45. Wang XM, Yew N, Peloquin JG, Vande Woude GF, Borisy GG. 1994. Mos oncogene product associates with kinetochores in mammalian somatic cells and disrupts mitotic progression. Proc Natl Acad Sci USA 91:8329-8333.
46. Yoon J, Deisboeck TS. 2009. Investigating differential dynamics of the MAPK signaling cascade using a multi-parametric global sensitivity analysis. PLoS ONE 4:e4560.
47. Yoon S, Seger R. 2006. The extracellular signal-regulated kinase: Multiple substrates regulate diverse cellular functions. Growth Factors 24:21-44.
48. Yun C, Cho H, Kim SJ, Lee JH, Park SY, Chan GK. 2004. Mitotic aberration coupled with centrosome amplification is induced by hepatitis B virus X oncoprotein via the Ras-mitogen-activated protein/extracellular signal-regulated kinase-mitogen-activated protein pathway. Mol Cancer Res 2: 159-169.
49. Zachara NE, Hart GW. 2006. Cell signaling, the essential role of O-GlcNAc. Biochim Biophys Acta 1761:599-617.